Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide

被引：0

作者：

Nikki McCaffrey

Tegan Asser

Belinda Fazekas

Wendy Muircroft

Meera Agar

Katherine Clark

Simon Eckermann

Jessica Lee

Rohit Joshi

Peter Allcroft

Caitlin Sheehan

David C. Currow

机构：

[1] Deakin University,Deakin Health Economics, Centre for Population Health Research, School of Health and Social Development

[2] Flinders University,Palliative & Supportive Services

[3] Flinders University,School of Medicine

[4] University of Technology,IMPACCT, Faculty of Health

[5] University of Technology Sydney,Australian National Cancer Symptom Trials Group

[6] Southern Adelaide Local Health Network,Southern Adelaide Palliative Services

[7] Liverpool Hospital,Cancer & Palliative Care Network

[8] South West Sydney Local Health District,Northern Clinical School

[9] Northern Sydney Local Health District,Centre for Health Service Development

[10] The University of Sydney,Concord Centre for Palliative Care

[11] Australian Health Services Research Institute,Medical Oncology

[12] University of Wollongong,Wolfson Palliative Care Research Centre

[13] Concord Repatriation General Hospital,undefined

[14] Lyell McEwin Hospital,undefined

[15] Calvary Heath Care,undefined

[16] University of Hull,undefined

来源：

BMC Cancer | / 20卷

关键词：

Patient-reported outcome measures; Neoplasms; Intestinal obstruction; Terminal care; Palliative care; Randomised controlled trials;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 18 条

[1] Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide
McCaffrey, Nikki
Asser, Tegan
Fazekas, Belinda
Muircroft, Wendy
Agar, Meera
Clark, Katherine
Eckermann, Simon
Lee, Jessica
Joshi, Rohit
Allcroft, Peter
Sheehan, Caitlin
Currow, David C.
BMC CANCER, 2020, 20 (01)
[2] Double-Blind, Placebo-Controlled, Randomized Trial of Octreotide in Malignant Bowel Obstruction
Currow, David C.
Quinn, Stephen
Agar, Meera
Fazekas, Belinda
Hardy, Janet
McCaffrey, Nikki
Eckermann, Simon
Abernethy, Amy P.
Clark, Katherine
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (05) : 814 - 821
[3] Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial
McCarney, Rob
Fisher, Peter
Iliffe, Steve
van Haselen, Robbert
Griffin, Mark
van der Meulen, Jan
Warner, James
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (12) : 1222 - 1230
[4] Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)
Wode, Kathrin
Nordberg, Johanna Hoek
Kienle, Gunver S.
Elander, Nils O.
Bernhardson, Britt-Marie
Sunde, Berit
Sharp, Lena
Henriksson, Roger
Fransson, Per
TRIALS, 2020, 21 (01)
[5] Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)
Kathrin Wode
Johanna Hök Nordberg
Gunver S. Kienle
Nils O. Elander
Britt-Marie Bernhardson
Berit Sunde
Lena Sharp
Roger Henriksson
Per Fransson
Trials, 21
[6] Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
Tanaka, Kosuke
Kessoku, Takaomi
Yamamoto, Atsushi
Takahashi, Kota
Kasai, Yuki
Ozaki, Anna
Iwaki, Michihiro
Kobayashi, Takashi
Yoshihara, Tsutomu
Misawa, Noboru
Kato, Takayuki
Arimoto, Jun
Fuyuki, Akiko
Sakai, Eiji
Higurashi, Takuma
Chiba, Hideyuki
Hosono, Kunihiro
Yoneda, Masato
Iwasaki, Tomoyuki
Kurihashi, Takeo
Nakatogawa, Machiko
Suzuki, Ayao
Taguri, Masataka
Oyamada, Shunsuke
Ariyoshi, Keisuke
Kobayashi, Noritoshi
Ichikawa, Yasushi
Nakajima, Atsushi
BMJ OPEN, 2022, 12 (05):
[7] Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial
Doerner, Thomas
Kaul, Martin
Szanto, Antonia
Tseng, Jui-Cheng
Papas, Athena S.
Pylvaenaeinen, Ilona
Hanser, Malika
Abdallah, Nasri
Grioni, Andrea
Santos Da Costa, Aida
Ferrero, Enrico
Gergely, Peter
Hillenbrand, Rainer
Avrameas, Alexandre
Cenni, Bruno
Siegel, Richard M.
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (03) : 360 - 371
[8] Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12-week multicentre, randomised, double-blind, and placebo-controlled phase IV study
Mori, Etsuro
Ikeda, Manabu
Iseki, Eizo
Katayama, Sadao
Nagahama, Yasuhiro
Ohdake, Megumi
Takase, Takao
PSYCHOGERIATRICS, 2024, 24 (03) : 542 - 554
[9] Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial
Bouleuc, Carole
Anota, Amelie
Cornet, Cecile
Grodard, Ghislain
Thiery-Vuillemin, Antoine
Dubroeucq, Olivier
Cretineau, Nathalie
Frasie, Veronique
Gamblin, Vincent
Chvetzoff, Gisele
Favier, Laure
Tournigand, Christophe
Grach, Marie-Christine
Raynard, Bruno
Salas, Sebastien
Capodano, Geraldine
Pazart, Lionel
Aubry, Regis
ONCOLOGIST, 2020, 25 (05): : E843 - E851
[10] Lack of Benefit From Paracetamol (Acetaminophen) for Palliative Cancer Patients Requiring High-Dose Strong Opioids: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Israel, Fiona J.
Parker, Greg
Charles, Margaret
Reymond, Liz
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (03) : 548 - 554

← 1 2 →